DO
DOCT.SW L&G Healthcare Breakthrough UCITS ETF CHF
- CHF
No recent price
- Total assets
- 56.9M
- Expense ratio
- 0.47%
- Dividend yield
- 0.43%
- 1-year return
- +41.49%
- Holdings
- 10
- Since
- 2019
Fund data as reported by the issuer, updated Oct 30, 2026. Total assets are in the fund's base currency.
What does DOCT.SW invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (79.3%)
- Largest sector: Healthcare (97.1%)
- Largest region: North America (79.7%)
- Top 3 holdings: 7.6% of the fund
Asset allocation
- US stocks 79.3%
- Non-US stocks 18.8%
- Cash 0.2%
Top holdings
- GRAIL, LLC 2.72%
- Twist Bioscience Corp 2.54%
- Natera Inc 2.31%
- Illumina Inc 2.21%
- Intuitive Surgical Inc 2.19%
L&G Healthcare Breakthrough UCITS ETF CHF performance
Sharpe ratio 0.80- This year
- +30.82%
- 1 year
- +41.49%
- 3 years
- +27.70%
- 5 years
- +0.56%
Volatility 18.5% over 1 year and 20.9% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DOCT.SW price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
L&G Healthcare Breakthrough UCITS ETF CHF top holdings
22.3% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| GRAIL, LLC GRAL.US | Healthcare | United States | 2.72% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 2.54% |
| Natera Inc NTRA.US | Healthcare | United States | 2.31% |
| Illumina Inc ILMN.US | Healthcare | United States | 2.21% |
| Intuitive Surgical Inc ISRG.US | Healthcare | United States | 2.19% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 2.18% |
| Tempus AI, Inc. Class A Common Stock TEM.US | Healthcare | United States | 2.09% |
| Guardant Health Inc GH.US | Healthcare | United States | 2.07% |
| Moderna Inc MRNA.US | Healthcare | United States | 2.06% |
| Medpace Holdings Inc MEDP.US | Healthcare | United States | 1.94% |
DOCT.SW sector exposure
- Healthcare97.1%
- Technology1.5%
Share of the stocks in the fund.
DOCT.SW regional exposure
- North America79.7%
- Europe Developed13.1%
- Asia Emerging2.4%
- United Kingdom2.0%
- Japan1.2%
Share of the stocks in the fund.
Company size
Average market cap 18.1B- Mega cap1.6%
- Big cap19.1%
- Medium cap36.3%
- Small cap27.7%
- Micro cap12.2%
L&G Healthcare Breakthrough UCITS ETF CHF fund profile
- Fund name
- L&G Healthcare Breakthrough UCITS ETF CHF
- Ticker
- DOCT.SW
- Exchange
- SIX Swiss Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Jun 26, 2019
- Trading currency
- CHF
- Expense ratio
- 0.47%